Farudodstat Tablets for Alopecia Areata
(FAST-AA Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
How is the drug Farudodstat different from other treatments for alopecia areata?
What is the purpose of this trial?
This trial is testing farudodstat, a medication that may help people with significant hair loss due to Alopecia Areata. The study focuses on adults who have lost 30% or more of their scalp hair. Farudodstat works by influencing body processes that control hair growth.
Research Team
Chief Medical Officer
Principal Investigator
ASLAN Pharmaceuticals
Eligibility Criteria
Adults over 18 years old with severe Alopecia Areata (AA) and at least 50% scalp hair loss can join this trial. They should have had AA for no more than 7 years, unless they've seen hair regrowth in that time. People are excluded if they have other types of alopecia, a history of certain hair conditions or treatments, or scalp diseases affecting assessment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either farudodstat or placebo for 12 weeks, followed by a crossover to the alternate treatment for another 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Farudodstat
- Placebo
Find a Clinic Near You
Who Is Running the Clinical Trial?
ASLAN Pharmaceuticals
Lead Sponsor